These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24037023)

  • 1. The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT.
    Marek A; Stern M; Chalandon Y; Ansari M; Ozsahin H; Güngör T; Gerber B; Kühne T; Passweg JR; Gratwohl A; Tichelli A; Seger R; Schanz U; Halter J; Stussi G;
    Bone Marrow Transplant; 2014 Jan; 49(1):55-61. PubMed ID: 24037023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.
    Anandi P; Tian X; Ito S; Muranski P; Chokshi PD; Watters N; Chawla U; Hensel N; Stroncek DF; Battiwalla M; Barrett AJ
    Cytotherapy; 2017 Jun; 19(6):735-743. PubMed ID: 28395942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34
    Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U
    Front Immunol; 2018; 9():1841. PubMed ID: 30154788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
    Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F
    Front Immunol; 2020; 11():699. PubMed ID: 32477328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ
    Diaz MA; Zubicaray J; Molina B; Abad L; Castillo A; Sebastian E; Galvez E; Ruiz J; Vicario JL; Ramirez M; Sevilla J; González-Vicent M
    Front Immunol; 2019; 10():2504. PubMed ID: 31736949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose alemtuzumab vs. standard policy for prevention of graft-versus-host disease in unrelated and related allogeneic stem cell transplantation-a matched pair analysis.
    Busemann C; Neumann T; Schulze M; Klenner A; Thiele T; Greinacher A; Dölken G; Krüger WH
    Ann Hematol; 2013 Jul; 92(7):945-52. PubMed ID: 23463451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.
    Lang P; Teltschik HM; Feuchtinger T; Müller I; Pfeiffer M; Schumm M; Ebinger M; Schwarze CP; Gruhn B; Schrauder A; Albert MH; Greil J; Urban C; Handgretinger R
    Br J Haematol; 2014 Jun; 165(5):688-98. PubMed ID: 24588540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
    Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem-cell transplantation from haploidentical donors using 'ex-vivo' T-cell depletion in pediatric patients with hematological malignancies: state of the art review.
    González-Vicent M; Díaz Perez MA
    Curr Opin Oncol; 2018 Nov; 30(6):396-401. PubMed ID: 30307414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of individualized graft composition: CD3/CD19 depletion combined with CD34 selection for haploidentical transplantation.
    Huenecke S; Bremm M; Cappel C; Esser R; Quaiser A; Bonig H; Jarisch A; Soerensen J; Klingebiel T; Bader P; Koehl U
    Transfusion; 2016 Sep; 56(9):2336-45. PubMed ID: 27346253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.
    Montoro J; Roldán E; Piñana JL; Barba P; Chorão P; Quintero A; Hernani R; Ortí G; Lorenzo JI; Balaguer-Roselló A; Salamero O; Fox L; Solves P; Gómez I; Guerreiro M; Hernández Boluda JC; Sanz G; Solano C; Sanz MÁ; Valcárcel D; Sanz J
    Eur J Haematol; 2021 Jan; 106(1):114-125. PubMed ID: 33025625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.
    Dodero A; Carniti C; Raganato A; Vendramin A; Farina L; Spina F; Carlo-Stella C; Di Terlizzi S; Milanesi M; Longoni P; Gandola L; Lombardo C; Corradini P
    Blood; 2009 May; 113(19):4771-9. PubMed ID: 19211934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.
    Bethge WA; Haegele M; Faul C; Lang P; Schumm M; Bornhauser M; Handgretinger R; Kanz L
    Exp Hematol; 2006 Dec; 34(12):1746-52. PubMed ID: 17157172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.
    Bhatt ST; Bednarski JJ; Berg J; Trinkaus K; Murray L; Hayashi R; Schulz G; Hente M; Grimley M; Chan KW; Kamani N; Jacobsohn D; Nieder M; Hale G; Yu L; Adams R; Dalal J; Pulsipher MA; Haut P; Chaudhury S; Davis J; Jaroscak J; Andreansky M; Willert J; Shenoy S
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):556-561. PubMed ID: 30321596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood.
    Oshrine BR; Li Y; Teachey DT; Heimall J; Barrett DM; Bunin N
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1581-9. PubMed ID: 23939199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation.
    Kanda Y; Oshima K; Kako S; Fukuda T; Uchida N; Miyamura K; Kondo Y; Nakao S; Nagafuji K; Miyamoto T; Kurokawa M; Okoshi Y; Chiba S; Ohashi Y; Takaue Y; Taniguchi S
    Am J Hematol; 2013 Apr; 88(4):294-300. PubMed ID: 23450467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancement of human leukocyte antigen-partially matched related hematopoietic stem cell transplantation.
    Mo X; Huang X
    Front Med; 2013 Sep; 7(3):306-15. PubMed ID: 23888376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH).
    Pérez-Martínez A; Ferreras C; Pascual A; Gonzalez-Vicent M; Alonso L; Badell I; Fernández Navarro JM; Regueiro A; Plaza M; Pérez Hurtado JM; Benito A; Beléndez C; Couselo JM; Fuster JL; Díaz-Almirón M; Bueno D; Mozo Y; Marsal J; Gómez López A; Sisinni L; de Heredia CD; Díaz MÁ
    Am J Hematol; 2020 Jan; 95(1):28-37. PubMed ID: 31625177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR α
    Mitchell R; Cole T; Shaw PJ; Mechinaud F; O'Brien T; Fraser C
    Pediatr Transplant; 2019 Sep; 23(6):e13517. PubMed ID: 31271477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT.
    Maier CP; Klose C; Seitz CM; Heubach F; Döring M; Meisel R; Schuster F; Gruhn B; Keller F; Rabsteyn A; Arendt AM; Amorelli G; Eichholz T; Feuchtinger T; Martinius H; Nierkens S; Teltschik R; Schulte JH; Lengerke C; Handgretinger R; Lang P
    Blood Adv; 2024 May; 8(9):2160-2171. PubMed ID: 38290133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.